These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8738141)

  • 1. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine.
    Rouillard C; Bovetto S; Gervais J; Richard D
    Brain Res Mol Brain Res; 1996 Apr; 37(1-2):105-15. PubMed ID: 8738141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons.
    Guerra MJ; Liste I; Labandeira-Garcia JL
    Synapse; 1998 Jan; 28(1):71-82. PubMed ID: 9414020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons.
    Gardier AM; Moratalla R; Cuéllar B; Sacerdote M; Guibert B; Lebrec H; Graybiel AM
    J Neurochem; 2000 Apr; 74(4):1363-73. PubMed ID: 10737591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM; Ye H; Pennypacker KR; Hudson PM; Hong JS
    Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Walker PD
    Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.
    Tremblay PO; Gervais J; Rouillard C
    Eur J Neurosci; 1998 Nov; 10(11):3546-55. PubMed ID: 9824467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats.
    Guo X; Ding YM; Hu JY; Jin GZ
    Life Sci; 1998; 62(25):2295-302. PubMed ID: 9651118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ; Coscina DV; Fletcher PJ
    Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
    Cook DF; Wirtshafter D
    Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-doses of methamphetamine on d-fenfluramine-induced head-twitch response (HTR) in mice during ageing and c-fos expression in the prefrontal cortex.
    Sun Y; Chebolu S; Skegrud S; Kamali S; Darmani NA
    BMC Neurosci; 2023 Jan; 24(1):2. PubMed ID: 36631757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
    Basura GJ; Walker PD
    Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE; Johnson KB; Jurevics HA; Criswell HE; Napier TC; Duncan GE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.
    Javed A; Van de Kar LD; Gray TS
    Brain Res; 1998 Apr; 791(1-2):67-74. PubMed ID: 9593827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems.
    Bhat RV; Baraban JM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):496-505. PubMed ID: 8229780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain.
    Richard D; Rivest S; Rivier C
    Brain Res; 1992 Oct; 594(1):131-7. PubMed ID: 1467932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.